Hemosiderosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
{{SK}} Idiopathic Pulmonary hemosiderosis; IPH; hemosiderin accumulation
{{SK}} Idiopathic Pulmonary hemosiderosis; IPH; hemosiderin accumulation


==[[Hemoptysis overview|Overview]]==
==[[Hemoptysis historical perspective|Historical Perspective]]==
==[[Hemoptysis pathophysiology|Pathophysiology]]==
==[[Hemoptysis causes|Causes]]==
==[[Hemoptysis differential diagnosis|Differentiating Hemoptysis from other Diseases]]==
==[[Hemoptysis epidemiology and demographics|Epidemiology and Demographics]]==
==[[Hemoptysis risk factors|Risk Factors]]==
==[[Hemoptysis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
==Diagnosis==
[[Hemoptysis diagnostic approach|Diagnostic Approach]] | [[Hemoptysis history and symptoms|History and Symptoms ]] | [[ Hemoptysis physical examination|Physical Examination]] | [[Hemoptysis laboratory findings|Laboratory Findings]] | [[Hemoptysis electrocardiogram|Electrocardiogram]] | [[Hemoptysis chest x ray|Chest X Ray]] | [[Hemoptysis CT|CT]] | [[Hemoptysis MRI|MRI]] | [[Hemoptysis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Hemoptysis other imaging findings|Other Imaging Findings]] | [[Hemoptysis other diagnostic studies|Other Diagnostic Studies]]
==Treatment==
[[Hemoptysis medical therapy|Medical Therapy]] | [[Hemoptysis surgery |Surgery]] | [[Hemoptysis primary prevention|Primary Prevention]] | [[Hemoptysis secondary prevention|Secondary Prevention]] | [[Hemoptysis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Hemoptysis future or investigational therapies|Future or Investigational Therapies]]
==Case Studies==
[[Hemoptysis case study one|Case #1]]
== Related Chapters ==
== Related Chapters ==
* [[Transfusion hemosiderosis]]
* [[Transfusion hemosiderosis]]

Revision as of 04:49, 25 September 2012

Hemosiderosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemosiderosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemosiderosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemosiderosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemosiderosis

CDC on Hemosiderosis

Hemosiderosis in the news

Blogs on Hemosiderosis

Directions to Hospitals Treating Hemosiderosis

Risk calculators and risk factors for Hemosiderosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Idiopathic Pulmonary hemosiderosis; IPH; hemosiderin accumulation

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Hemoptysis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Approach | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

Template:WH Template:WS